Facilitated By

San Antonio Medical Foundation

A RANDOMIZED, MULTICOUNTRY, MULTICENTER, DOUBLE-BLIND, PARALLEL, PLACEBO-CONTROLLED STUDY OF THE EFFECTS OF ATRASENTAN ON RENAL OUTCOMES IN SUBJECTS WITH TYPE 2 DIABETES AND NEPHROPATHY-SONAR: STUDY OF DIABETIC NEPHROPATHY WITH ATRASENTAN.

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Bansal,Shweta
Funded by
ABBVIE INC.
Research Start Date
Status
Inactive
Clinical Care
Drug Discovery
Diabetes and Obesity